Clinical Trials in Los Angeles

Showing 3781-3800 of 16,901 trials

Study to Evaluate the Efficacy & Safety of the INTERCEPT Blood System for RBCs in Complex Cardiac Surgery Patients

NCT03459287

The objective of this study is to evaluate the efficacy and safety of RBC transfusion for support of acute anemia in cardiovascular surgery patients based on the clinical outcome of renal impairment following transfusion of red blood cells (RBCs) treated with the INTERCEPT Blood System (IBS) for Red Blood Cells compared to patients transfused with conventional RBCs.

Anemia

Cerus Corporation581 participantsStarted Dec 2018

Los Angeles, California, United States • Stanford, California, United States • Aurora, Colorado, United States +15 more locations

RECRUITINGPhase 2< 1 mile

A Phase 2 Study of YA-101 in Patients With Multiple System Atrophy

NCT06848231

This is a Phase 2, double-blind, placebo-controlled, multi-center, Phase II, dose escalation study to evaluate the safety, tolerability, pharmacokinetics and efficacy of Ya-101 in subjects with multiple system atrophy.

Multiple System Atrophy

Yoda Therapeutics Inc.75 participantsStarted Mar 2025

Los Angeles, California, United States • Boston, Massachusetts, United States • Rochester, Minnesota, United States +6 more locations

Study to Evaluate the Efficacy & Safety of the INTERCEPT Blood System for RBCs in Complex Cardiac Surgery Patients

A Phase 2 Study of YA-101 in Patients With Multiple System Atrophy

Find Trials by Condition in Los Angeles

Evaluation of Rifaximin SSD for Delaying Encephalopathy Decompensation in Patients With Cirrhosis

Abatacept in Immune Checkpoint Inhibitor Myocarditis

A Study of mRNA-1010 Compared With a Licensed Influenza Vaccine in Adults ≥50 Years of Age

A Study Comparing Venetoclax and Azacitidine Plus Cusatuzumab to Venetoclax and Azacitidine in Newly Diagnosed AML Ineligible for Intensive Therapy

A Study to Evaluate Efficacy and Safety of Deucravacitinib in Participants With Active Discoid and/or Subacute Cutaneous Lupus Erythematosus (DLE/SCLE)

Examining Distinct Immunophenotypes to Validate and Enhance Rational Treatment in Systemic Lupus

First-in-Human Study of OKI-219 in Advanced Solid Tumors and Advanced Breast Cancer

A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression

A Study of LM-24C5 For Advanced Solid Tumors

A Single and Multiple Ascending Dose Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD2389 in Healthy Participants

FebriDx® Method Comparison Study Protocol

A Trial of Centanafadine Efficacy, Safety, and Tolerability in Adult Subjects With Binge Eating Disorder

Phase 1 Trial in Patients With Human Papillomavirus (HPV)-Associated Cancer

A Safety/Tolerability and PK Study With Azstarys® in Children With ADHD

A Study of Efficacy and Safety of Pembrolizumab Plus Enfortumab Vedotin (EV) +/- Investigational Agents in First-Line Metastatic Urothelial Carcinoma (mUC) (MK-3475-04B/KEYMAKER-U04)

Study of Cabozantinib in Combination With Nivolumab and Ipilimumab in Patients With Previously Untreated Advanced or Metastatic Renal Cell Carcinoma

OCS DCD Heart + CAP Continued Follow-Up

A Study to Evaluate the Effect of Deucravacitinib on Quality of Life in Participants With Plaque Psoriasis in a Community Setting